Under construction – not a live service
Sign in
Taking people in DenmarkNo phase

Measuring Fitness in People With Severe Mental Illness

Tests ways to measure fitness in adults with severe mental illness and healthy controls.

Plain-language title generated from the registry record
Registry title: Validation and Impact of Cardiorespiratory Fitness in Severe Mental Illness - the Heart in Mind Project

Key facts

Where
Glostrup Municipality, DenmarkSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 45 years old?

Source: NCT06743711, who can take part

Where in Denmark

  • Mental Health Center GlostrupGlostrup Municipality, DenmarkTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Bjorn H. Ebdrup
Trial code
NCT06743711
Record updated
4 May 2026
Original description
This project aims to evaluate feasibility, validity and clinically applicability to systematically measure fitness in patients with severe mental illness.Read full original descriptionShow less

Validation and Impact of Cardiorespiratory Fitness in Severe Mental Illness - the Heart in Mind Project

This project aims to evaluate feasibility, validity and clinically applicability to systematically measure fitness in patients with severe mental illness.

The research project is a validation study using a cross-sectional design. The project will include 50 people with severe mental illness and 25 healthy controls without present or previous mental illness. The protocol includes a baseline visit where three different ways of measure fitness will be carried out, and a 14-day period of physical activity monitoring.

Inclusion: 18-45 years; Diagnosis within schizophrenia spectrum or affective disorders (i.e. F2.x or F3.x according to ICD-10 classification); current antipsychotic treatment for more than one month on a regular daily dose; Able to give informed consent.

Exclusion: Unstable psychiatric disorder; Clinical or laboratory evidence of uncompensated medical disease; Acute suicidal risk; Planned hospitalization within the study period.

ClinicalTrials.gov NCT06743711